Literature DB >> 28828662

In Vivo Tracking of Extracellular Vesicles in Mice Using Fusion Protein Comprising Lactadherin and Gaussia Luciferase.

Yuki Takahashi1, Makiya Nishikawa2, Yoshinobu Takakura2.   

Abstract

Extracellular vesicles (EVs) are cell-derived vesicles comprising a lipid bilayer and are found in body fluids, such as blood, sweat, and urine. As EVs, especially exosomes, function as endogenous intercellular delivery tools, their roles in various biological events have been extensively investigated. In addition, they are expected to become safe and effective drug delivery systems (DDS) because of their intrinsic nature. In the development of EV-based DDS, as well as in the investigation of the biological functions of EVs, it is important to analyze the in vivo behavior of EVs by tracking them. Therefore, we have developed a sensitive EV-labeling method to track EVs in vivo by designing a fusion protein comprising lactadherin (LA) (alias milk fat globule-EGF factor 8), a protein that binds to EV membranes through interaction with phosphatidylserine, and Gaussia luciferase (gLuc), a chemiluminescent protein. gLuc-LA-labeled EVs are easily obtained by transfecting EV-producing cells with a gLuc-LA-encoding plasmid vector. Here, we describe methods to label EVs with the fusion protein and to track the labeled EVs in vivo.

Entities:  

Keywords:  Exosomes; Extracellular vesicles; Gaussia luciferase; In vivo imaging; Lactadherin

Mesh:

Substances:

Year:  2017        PMID: 28828662     DOI: 10.1007/978-1-4939-7253-1_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

Review 1.  Reporter Systems for Assessments of Extracellular Vesicle Transfer.

Authors:  Chaoshan Han; Gangjian Qin
Journal:  Front Cardiovasc Med       Date:  2022-06-01

2.  Extracellular Vesicles Containing IL-4 Modulate Neuroinflammation in a Mouse Model of Multiple Sclerosis.

Authors:  Giacomo Casella; Federico Colombo; Annamaria Finardi; Hélène Descamps; Gerard Ill-Raga; Antonello Spinelli; Paola Podini; Mattia Bastoni; Gianvito Martino; Luca Muzio; Roberto Furlan
Journal:  Mol Ther       Date:  2018-07-05       Impact factor: 11.454

Review 3.  Exosomes in atherosclerosis: performers, bystanders, biomarkers, and therapeutic targets.

Authors:  Chen Wang; Zhelong Li; Yunnan Liu; Lijun Yuan
Journal:  Theranostics       Date:  2021-02-15       Impact factor: 11.556

4.  GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain.

Authors:  Ghulam Hassan Dar; Cláudia C Mendes; Wei-Li Kuan; Alfina A Speciale; Mariana Conceição; André Görgens; Inna Uliyakina; Miguel J Lobo; Wooi F Lim; Samir El Andaloussi; Imre Mäger; Thomas C Roberts; Roger A Barker; Deborah C I Goberdhan; Clive Wilson; Matthew J A Wood
Journal:  Nat Commun       Date:  2021-11-18       Impact factor: 14.919

Review 5.  Endothelial Senescence and the Chronic Vascular Diseases: Challenges and Therapeutic Opportunities in Atherosclerosis.

Authors:  Rafael Ramírez; Noemi Ceprian; Andrea Figuer; Gemma Valera; Guillermo Bodega; Matilde Alique; Julia Carracedo
Journal:  J Pers Med       Date:  2022-02-04

6.  In vivo imaging of long-term accumulation of cancer-derived exosomes using a BRET-based reporter.

Authors:  Tomoya Hikita; Mamiko Miyata; Risayo Watanabe; Chitose Oneyama
Journal:  Sci Rep       Date:  2020-10-06       Impact factor: 4.379

Review 7.  Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies.

Authors:  Meng Xu; Tao Feng; Bowen Liu; Fen Qiu; Youhua Xu; Yonghua Zhao; Ying Zheng
Journal:  Theranostics       Date:  2021-08-18       Impact factor: 11.556

Review 8.  Extracellular vesicles in the development of organ-specific metastasis.

Authors:  Fumihiko Urabe; Kalyani Patil; Grant A Ramm; Takahiro Ochiya; Carolina Soekmadji
Journal:  J Extracell Vesicles       Date:  2021-07-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.